Amrutanjan Health Care Limited (BOM:590006)
India · Delayed Price · Currency is INR 625.60
+12.95 (2.11%)
At close: Jan 22, 2026
Amrutanjan Health Care Revenue
Amrutanjan Health Care had revenue of 1.18B INR in the quarter ending September 30, 2025, with 7.08% growth. This brings the company's revenue in the last twelve months to 4.70B, up 7.36% year-over-year. In the fiscal year ending March 31, 2025, Amrutanjan Health Care had annual revenue of 4.52B with 7.26% growth.
Revenue (ttm)
4.70B
Revenue Growth
+7.36%
P/S Ratio
3.73
Revenue / Employee
6.38M
Employees
737
Market Cap
17.52B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2025 | 4.52B | 305.93M | 7.26% |
| Mar 31, 2024 | 4.21B | 416.12M | 10.96% |
| Mar 31, 2023 | 3.80B | -261.89M | -6.45% |
| Mar 31, 2022 | 4.06B | 729.35M | 21.90% |
| Mar 31, 2021 | 3.33B | 712.64M | 27.23% |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Unichem Laboratories | 22.26B |
| Morepen Laboratories | 17.56B |
| Hikal | 16.99B |
| Gufic Biosciences | 8.74B |
| Bliss GVS Pharma | 8.60B |
| TTK Healthcare | 8.31B |
| Venus Remedies | 6.99B |
| Syncom Formulations (India) | 5.15B |
Amrutanjan Health Care News
- 2 months ago - Amrutanjan Healthcare Re-launches Its Iconic Yellow Balm in Classic Glass Packaging - Business Upturn